Practical usage of ciclosporin 0.09% for moderate-severe dry eye disease
Date: 3/04/2024 (AEDT)
Venue: QT Hotel, 49 Market Street, Sydney, NSW, 2000
Provider: Sun Pharma ANZ
Contact: https://lms.optometry.org.au/course/view.php?id=726
Activity Outline
Join our interactive CPD educational dinner event at QT Hotel Sydney where Margaret Lam (National President Optometry Australia, National Vice President Cornea and Contact Lens Society) will explore the role of Cequa (ciclosporin 0.09%) in the management of moderate to severe dry eye disease and discuss the practical considerations with its usage, including prescribing, patient selection and patient education. Real-life clinical application to achieve best patient outcomes using Cequa will be examined through case studies and interactive discussions.
For further details and to register for the event, please click the link below:
Learning Objectives
- Understand why treating underlying inflammation is important in moderate-severe dry eye disease for long term disease management
- Understand the role of ciclosporin 0.09% in the management of moderate-severe dry eye disease
- Develop a deeper understanding of the practical considerations in ciclosporin 0.09% management therapy including patient education, prescribing and expectations
- Understand how to utilise ciclosporin 0.09% for moderate-severe dry eye disease in clinical practice for best patient outcomes
Max CPD hours awarded: 2.5
Session Information
| Name |
|---|
| Practical use of ciclosporin 0.09% in moderate-severe dry eye disease |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 2.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 2.5 |